Omada Health Business Summary

Omada Health, Inc. (OMDA) is a virtual-first healthcare provider specializing in chronic disease management through evidence-based digital care programs designed to support patients between traditional doctor visits. The company generates revenue primarily through value-based pricing and performance-based contracts with over 2,000 enterprise customers, including employers, health plans, and health systems. Its primary business segments encompass cardiometabolic health (prediabetes, type 2 diabetes, and hypertension), musculoskeletal (MSK) care, and behavioral health support. As of early 2026, Omada has significantly expanded its high-margin revenue streams by integrating a GLP-1 medication management track and deploying AI-powered coaching tools like OmadaSpark and Meal Map to enhance member engagement and clinical outcomes. Within the competitive landscape, Omada competes directly with Teladoc Health (Livongo), Noom, Hinge Health, and Welldoc, positioning itself as a clinically validated leader in long-term behavior change and integrated multi-condition care. Founded in 2011 by Sean Duffy, Adrian James, and Andrew DiMichele, Omada Health is led by Co-founder and CEO Sean Duffy, who holds an MD/MBA from Harvard and previously founded Excel Everest. The executive leadership team includes President Wei-Li Shao, a former Eli Lilly executive; Chief Financial Officer Steve Cook, who previously held senior finance roles at One Medical and Salesforce; and Chief Technology Officer Sunil Kayiti. In late 2025, the company appointed Dr. Thomas Tsang, former founding CEO of Valera Health and CMO of Merck Healthcare Services, as its Chief Medical Officer to oversee clinical strategy. Omada is governed by a board chaired by Jeryl "Jeri" Hilleman and has secured approximately $450 million in funding from prominent institutional investors, including Fidelity Investments, Andreessen Horowitz (a16z), New Enterprise Associates (NEA), Perceptive Advisors, and Wellington Management.